Float Short %

0.71

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.04

EPS Last/This Y

1.44

EPS This/Next Y

0.25

Price

0.04

Target Price

31.67

Analyst Recom

Performance Q

Upside

N/A

Beta

Ticker: AKTS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	AKTS	21.65	N/A	N/A	0
2026-01-26	AKTS	21.64	N/A	N/A	0
2026-01-27	AKTS	21.13	N/A	N/A	0
2026-01-28	AKTS	20.47	N/A	N/A	0
2026-01-29	AKTS	19.64	N/A	N/A	0
2026-01-30	AKTS	20.18	N/A	N/A	0
2026-02-02	AKTS	21.96	N/A	N/A	0
2026-02-03	AKTS	20.82	N/A	N/A	0
2026-02-04	AKTS	19.89	N/A	N/A	0
2026-02-05	AKTS	19.52	N/A	N/A	0
2026-02-06	AKTS	18.91	N/A	N/A	0
2026-02-09	AKTS	18.98	N/A	N/A	0
2026-02-10	AKTS	17.86	N/A	N/A	0
2026-02-11	AKTS	18.08	N/A	N/A	0
2026-02-12	AKTS	17.93	N/A	N/A	0
2026-02-13	AKTS	17.77	N/A	N/A	0
2026-02-17	AKTS	17.91	N/A	N/A	0
2026-02-18	AKTS	17.73	N/A	N/A	0
2026-02-20	AKTS	18.9	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	AKTS	18.49	5.54	0
2026-01-26	AKTS	18.49	5.54	0
2026-01-27	AKTS	18.49	5.54	0
2026-01-28	AKTS	34.85	5.54	0.17
2026-01-29	AKTS	34.85	5.54	0.17
2026-01-30	AKTS	34.85	5.54	0.17
2026-02-02	AKTS	34.85	5.54	0.17
2026-02-03	AKTS	34.85	5.54	0.17
2026-02-04	AKTS	34.85	5.54	0.17
2026-02-05	AKTS	34.85	5.54	0.17
2026-02-06	AKTS	34.85	5.54	0.17
2026-02-10	AKTS	34.85	5.54	0.17
2026-02-11	AKTS	34.85	5.54	0.70
2026-02-12	AKTS	34.17	5.54	0.71
2026-02-13	AKTS	34.17	5.54	0.71
2026-02-17	AKTS	34.17	5.54	0.71
2026-02-18	AKTS	34.17	5.54	0.71
2026-02-19	AKTS	34.17	5.54	0.71
2026-02-20	AKTS	34.17	5.54	0.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

34.17

Institutional Transactions

5.54

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

-99.8

Target Price

31.67

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

-0.45

EPS Next Y. (Est.)

-0.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.64

Return on Equity vs Sector %

183.5

Return on Equity vs Industry %

216.6

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.09

EBIT Estimation

Aktis Oncology, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees:

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.

stock quote shares AKTS – Akoustis Technologies Inc Stock Price stock today

news today AKTS – Akoustis Technologies Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AKTS – Akoustis Technologies Inc yahoo finance google finance

stock history AKTS – Akoustis Technologies Inc invest stock market

stock prices AKTS premarket after hours

ticker AKTS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AKTS

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y